India needs innovative strategies to eliminate TB
The article highlights India's urgent need for innovative strategies to eliminate Tuberculosis (TB), which remains a leading infectious killer. It discusses the limitations of current approaches and the immense burden of TB in India, emphasizing a holistic strategy involving better detection, preventive therapy, and targeted vaccination. Promising results from the ICMR-led PreVenTB trial for VPM1002 and Immuvac vaccines against both pulmonary and extrapulmonary TB are presented. The authors advocate for deploying available, moderately effective tools, supported by nutritional interventions, rather than waiting for a perfect solution, drawing parallels with India's past public health decisions regarding indigenous vaccines and diagnostics.
Read analysis